Wed Jul 26 2017 22:15 ET
There was a significant insider sale of Spark Therapeutics shares today, as disclosed in a filing with the SEC as — Dr Anand Mehra, Director — disposed of 211,858 shares in the company having a market value of approximately $14,861,993 There have been 2 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the disposition of 846,302 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 1,058,160 shares and have averaged 352,720 shares per transaction over this time period.
In relation to the peer group over the last 90 days, insider buy/sell trading at Spark Therapeutics is above the 260-company peer group average. Bio Therapeutic Drugs peer group saw 324 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for Spark Therapeutics insiders was also higher. Within the peer group there were 9,094,849 shares purchased and 15,458,906 shares sold with company insiders selling 19,642 shares on average.
Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data sourced in creating and writing this story.
Using proprietary artificial intelligence methods, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.